Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery
NCT00939978
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Cardiac Surgery
Interventions
DRUG:
rhEPO
Sponsor
Yonsei University